These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19638584)

  • 21. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.
    Larsson P; Syed Khaja AS; Semenas J; Wang T; Sarwar M; Dizeyi N; Simoulis A; Hedblom A; Wai SN; Ødum N; Persson JL
    Int J Cancer; 2020 Mar; 146(6):1686-1699. PubMed ID: 31381135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.
    Sun P; Gao J; Liu YL; Wei LW; Wu LP; Liu ZY
    Mol Cell Biochem; 2008 Jan; 308(1-2):161-8. PubMed ID: 17938864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.
    Timoshenko AV; Rastogi S; Lala PK
    Br J Cancer; 2007 Oct; 97(8):1090-8. PubMed ID: 17912247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
    He XW; Liu T; Xiao Y; Feng YL; Cheng DJ; Tingting G; Zhang L; Zhang Y; Chen YX; Tingting G; Zhang L
    Cancer Biother Radiopharm; 2009 Apr; 24(2):249-59. PubMed ID: 19409048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.
    Tahir SA; Park S; Thompson TC
    Cancer Biol Ther; 2009 Dec; 8(23):2286-96. PubMed ID: 19923922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LPA
    Lin YC; Chen CC; Chen WM; Lu KY; Shen TL; Jou YC; Shen CH; Ohbayashi N; Kanaho Y; Huang YL; Lee H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1305-1315. PubMed ID: 30053596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.
    Fan F; Gray MJ; Dallas NA; Yang AD; Van Buren G; Camp ER; Ellis LM
    Mol Cancer Ther; 2008 Sep; 7(9):3064-70. PubMed ID: 18790786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
    Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
    Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
    Jennbacken K; Vallbo C; Wang W; Damber JE
    Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer.
    Li Q; Fu GB; Zheng JT; He J; Niu XB; Chen QD; Yin Y; Qian X; Xu Q; Wang M; Sun AF; Shu Y; Rui H; Liu LZ; Jiang BH
    Biochim Biophys Acta; 2013 Dec; 1833(12):3375-3385. PubMed ID: 24113386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C.
    Moussai D; Mitsui H; Pettersen JS; Pierson KC; Shah KR; Suárez-Fariñas M; Cardinale IR; Bluth MJ; Krueger JG; Carucci JA
    J Invest Dermatol; 2011 Jan; 131(1):229-36. PubMed ID: 20827282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.
    Watanabe K; Hirata M; Tominari T; Matsumoto C; Fujita H; Yonekura K; Murphy G; Nagase H; Miyaura C; Inada M
    J Biol Chem; 2016 Sep; 291(40):20891-20899. PubMed ID: 27539855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.
    Bender RJ; Mac Gabhann F
    BMC Syst Biol; 2015 Sep; 9():55. PubMed ID: 26341082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.
    Müller-Deile J; Worthmann K; Saleem M; Tossidou I; Haller H; Schiffer M
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1656-67. PubMed ID: 19828679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells.
    Yu HS; Wang SW; Chang AC; Tai HC; Yeh HI; Lin YM; Tang CH
    Biochem Pharmacol; 2014 Jan; 87(2):243-53. PubMed ID: 24225154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
    Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
    Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
    Roca H; Varsos ZS; Pienta KJ
    Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.